mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging

Repertoires of Autophagy in the Pathogenesis of Ocular Diseases

Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351 · see citing works

The 1982 revised criteria for the classification of systemic lupus erythematosus

Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519 · see citing works

On the origin of cancer cells

Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · see citing works

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409 · see citing works

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203 · see citing works

Surfing the p53 network

Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · see citing works

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

Petri, M., Orbai, A., Alarcón, G. S., Gordon, C., Merrill, J. T., Fortin, P. R., Bruce, I. N., Isenberg, D., Wallace, D. J., Nived, O., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34473 · Cited by 5,322 · see citing works

Systemic Lupus Erythematosus

Tsokos, G. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37754-6.50094-4 · Cited by 3,990 · see citing works

Rapamycin fed late in life extends lifespan in genetically heterogeneous mice

Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766 · see citing works

The AMPK signalling pathway coordinates cell growth, autophagy and metabolism

Mihaylova, M. M., & Shaw, R. J. (2011) · Nature Cell Biology · doi:10.1038/ncb2329 · Cited by 2,923 · see citing works

Systemic Lupus Erythematosus

Tsokos, G. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1100359 · Cited by 2,747 · see citing works

The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation

Wang, R., Dillon, C. P., Shi, L. Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L. L., Fitzgerald, P., Chi, H., Munger, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.021 · Cited by 2,140 · see citing works

Activation of a metabolic gene regulatory network downstream of mTOR complex 1

Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020 · see citing works

An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1

Thoreen, C. C., Kang, S. A., Chang, J. W., Liu, Q., Zhang, J., Gao, Y., Reichling, L. J., Sim, T., Sabatini, D. M., & Gray, N. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900301200 · Cited by 1,803 · see citing works

PI3K: Downstream AKTion Blocks Apoptosis

Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81883-8 · Cited by 1,692 · see citing works

Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.

Vézina, C., KUDELSKI, A., & Sehgal, S. N. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.721 · Cited by 1,691 · see citing works

Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1

Dang, E. V., Barbi, J., Yang, H.-Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.-R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.033 · Cited by 1,595 · see citing works

mTOR regulates memory CD8 T-cell differentiation

Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575 · see citing works

RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs

Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509 · see citing works

Ablation in Mice of the mTORC Components raptor, rictor, or mLST8 Reveals that mTORC2 Is Required for Signaling to Akt-FOXO and PKCα, but Not S6K1

Guertin, D. A., Stevens, D. M., Thoreen, C. C., Burds, A. A., Kalaany, N. Y., Moffat, J., Brown, M., Fitzgerald, K. J., & Sabatini, D. M. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.007 · Cited by 1,409 · see citing works

Regulation of 4E-BP1 phosphorylation: a novel two-step mechanismPreprint

Gingras, A., Gygi, S. P., Raught, B., Polakiewicz, R. D., Abraham, R. T., Hoekstra, M. F., Aebersold, R. H., & Sonenberg, N. (1999) · Genes & Development · doi:10.1101/gad.13.11.1422 · Cited by 1,348 · see citing works

HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations

Semenza, G. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67230 · Cited by 1,335 · see citing works

The coordinate regulation of the p53 and mTOR pathways in cells

Feng, Z., Zhang, H., Levine, A. J., & Jin, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502857102 · Cited by 1,235 · see citing works

Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity

Lamming, D. W., Ye, L., Katajisto, P., Goncalves, M. D., Saitoh, M., Stevens, D. M., Davis, J. G., Salmon, A. B., Richardson, A., Ahima, R. S., et al. (2012) · Science · doi:10.1126/science.1215135 · Cited by 1,199 · see citing works

The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2

Delgoffe, G. M., Pollizzi, K. N., Waickman, A. T., Heikamp, E., Meyers, D. J., Horton, M. R., Xiao, B., Worley, P. F., & Powell, J. D. (2011) · Nature Immunology · doi:10.1038/ni.2005 · Cited by 1,111 · see citing works

Efficacy and safety of sirolimus in lymphangioleiomyomatosis

McCormack, F. X., Inoue, Y., Moss, J., Singer, L. G., Strange, C., Nakata, K., Barker, A. F., Chapman, J. T., Brantly, M. L., Stocks, J. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100391 · Cited by 1,099 · see citing works

A Tumor Suppressor Complex with GAP Activity for the Rag GTPases That Signal Amino Acid Sufficiency to mTORC1

Bar-Peled, L., Chantranupong, L., Cherniack, A. D., Chen, W. W., Ottina, K. A., Grabiner, B. C., Spear, E. D., Carter, S. L., Meyerson, M., & Sabatini, D. M. (2013) · Science · doi:10.1126/science.1232044 · Cited by 1,080 · see citing works

Regulation and function of mTOR signalling in T cell fate decisions

Chi, H. (2012) · Nature Reviews Immunology · doi:10.1038/nri3198 · Cited by 1,035 · see citing works

Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis

Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D. J., Ramesh, V., & Silva, A. J. (2008) · Nature Medicine · doi:10.1038/nm1788 · Cited by 879 · see citing works

AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity

Chresta, C. M., Davies, B. R., Hickson, I., Harding, T. C., Cosulich, S. C., Critchlow, S. E., Vincent, J. P., Ellston, R. P. A., Jones, D., Sini, P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1751 · Cited by 796 · see citing works

Sirolimus: its discovery, biological properties, and mechanism of action

Sehgal, S. N. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00211-2 · Cited by 784 · see citing works

mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6

Nazio, F., Strappazzon, F., Antonioli, M., Bielli, P., Cianfanelli, V., Bordi, M., Gretzmeier, C., Dengjel, J., Piacentini, M., Fimia, G. M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2708 · Cited by 783 · see citing works

Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1

Ben-Sahra, I., Howell, J. J., Asara, J. M., & Manning, B. D. (2013) · Science · doi:10.1126/science.1228792 · Cited by 739 · see citing works

Drug-Eluting Coronary-Artery Stents

Stefanini, G. G., & Holmes, D. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1210816 · Cited by 737 · see citing works

Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation

Gerriets, V. A., Kishton, R. J., Nichols, A., Macintyre, A. N., Inoue, M., Ilkayeva, O., Winter, P. S., Liu, X., Priyadharshini, B., Slawinska, M. E., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76012 · Cited by 729 · see citing works

The Pathogenesis of the Antiphospholipid Syndrome

Giannakopoulos, B., & Krilis, S. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1112830 · Cited by 682 · see citing works

mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells

Chen, C., Liu, Y., Liu, Y., & Zheng, P. (2009) · Science Signaling · doi:10.1126/scisignal.2000559 · Cited by 680 · see citing works

Regulation of mTORC1 and its impact on gene expression at a glance

Laplante, M., & Sabatini, D. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.125773 · Cited by 665 · see citing works

Activation of mTORC2 by Association with the Ribosome

Zinzalla, V., Stracka, D., Oppliger, W., & Hall, M. N. (2011) · Cell · doi:10.1016/j.cell.2011.02.014 · Cited by 648 · see citing works

The Regulation of AMPK β1, TSC2, and PTEN Expression by p53: Stress, Cell and Tissue Specificity, and the Role of These Gene Products in Modulating the IGF-1-AKT-mTOR Pathways

Feng, Z., Hu, W., de Stanchina, E., Teresky, A. K., Jin, S., Lowe, S., & Levine, A. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4149 · Cited by 633 · see citing works

Rapamycin‐mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction

Miller, R. A., Harrison, D. E., Astle, C. M., Fernández, E., Flurkey, K., Han, M. L., Javors, M. A., Li, X., Nadon, N. L., Nelson, J. F., et al. (2013) · Aging Cell · doi:10.1111/acel.12194 · Cited by 618 · see citing works

Normalization of CD4 + T cell metabolism reverses lupus

Yin, Y., Choi, S., Xu, Z., Perry, D. J., Seay, H. R., Croker, B. P., Sobel, E. S., Brusko, T. M., & Morel, L. M. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa0835 · Cited by 611 · see citing works

PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells

Finlay, D. K., Rosenzweig, E., Sinclair, L. V., Feijoo-Carnero, C., Hukelmann, J. L., Rolf, J., Panteleyev, A. A., Okkenhaug, K., & Cantrell, D. A. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112607 · Cited by 596 · see citing works

Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth

Sun, Q., Chen, X., Ma, J., Peng, H., Wang, F., Zha, X., Wang, Y., Jing, Y., Yang, H., Chen, R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014769108 · Cited by 586 · see citing works

Increased Activation of the Mammalian Target of Rapamycin Pathway in Liver and Skeletal Muscle of Obese Rats: Possible Involvement in Obesity-Linked Insulin Resistance

Khamzina, L., Veilleux, A., Bergeron, S., & Marette, A. (2005) · Endocrinology · doi:10.1210/en.2004-0921 · Cited by 562 · see citing works

Hepatic mTORC2 Activates Glycolysis and Lipogenesis through Akt, Glucokinase, and SREBP1c

Hagiwara, A., Cornu, M., Cybulski, N., Polak, P., Betz, C., Trapani, F., Terracciano, L., Heim, M. H., Rüegg, M. A., & Hall, M. N. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.015 · Cited by 551 · see citing works

Risk Factors for Cardiovascular Disease in Systemic Lupus Erythematosus

Svenungsson, E., Jensen‐Urstad, K., Heimbürger, M., Silveira, A. M. V., Hamsten, A., Fairé, U. D., Witztum, J. L., & Frostegård, J. (2001) · Circulation · doi:10.1161/hc4101.097518 · Cited by 500 · see citing works

Dissecting the role of mTOR: Lessons from mTOR inhibitors

Dowling, R. J. O., Topisirović, I., Fonseca, B. D., & Sonenberg, N. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.12.001 · Cited by 459 · see citing works

Chronic Rapamycin Treatment Causes Glucose Intolerance and Hyperlipidemia by Upregulating Hepatic Gluconeogenesis and Impairing Lipid Deposition in Adipose Tissue

Houde, V. P., Brûlé, S., Festuccia, W. T., Blanchard, P.-G., Bellmann, K., Deshaies, Y., & Marette, A. (2010) · Diabetes · doi:10.2337/db09-1324 · Cited by 456 · see citing works

mTORC1-Activated S6K1 Phosphorylates Rictor on Threonine 1135 and Regulates mTORC2 Signaling

Julien, L.-A., Carriere, A., Moreau, J., & Roux, P. P. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00601-09 · Cited by 433 · see citing works

Ex vivo expansion, adipogenesis and neurogenesis of cryopreserved human bone marrow mesenchymal stem cells

Xiang, Y., Zheng, Q., Jia, B., Huang, G., Xie, C., Pan, J., & Wang, J. (2006) · Cell Biology International · doi:10.1016/j.cellbi.2006.11.012 · Cited by 429 · see citing works

<i>N</i> ‐acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double‐blind, placebo‐controlled trial

Lai, Z., Hanczko, R., Bonilla, E., Caza, T. N., Clair, B., Bartos, A., Miklossy, G., Jimah, J., Doherty, E., Tily, H., et al. (2012) · Arthritis &amp; Rheumatism · doi:10.1002/art.34502 · Cited by 428 · see citing works

T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis.

Shivakumar, S., Tsokos, G. C., & Datta, S. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.1.103 · Cited by 405 · see citing works

mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in Mice

Guertin, D. A., Stevens, D. M., Saitoh, M., Kinkel, S., Crosby, K., Sheen, J.-H., Mullholland, D. J., Magnuson, M. A., Wu, H., & Sabatini, D. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.017 · Cited by 402 · see citing works

mTOR Inhibition by Rapamycin Prevents β-Cell Adaptation to Hyperglycemia and Exacerbates the Metabolic State in Type 2 Diabetes

Fraenkel, M., Ketzinel‐Gilad, M., Ariav, Y., Pappo, O., Karaca, M., Castel, J., Berthault, M., Magnan, C., Cerasi, E., Kaiser, N., et al. (2008) · Diabetes · doi:10.2337/db07-0922 · Cited by 380 · see citing works

The Antioxidant Acetylcysteine Reduces Cardiovascular Events in Patients With End-Stage Renal Failure

Tepel, M., van der Giet, M., Statz, M., Jankowski, J., & Zidek, W. (2003) · Circulation · doi:10.1161/01.cir.0000050628.11305.30 · Cited by 375 · see citing works

RAPAMYCIN FOR IMMUNOSUPPRESSION IN ORGAN ALLOGRAFTING

Calne, R. Y., Lim, S. M. L., Samaan, A., Collier, D. S., Pollard, S. G., White, D. J., & Thiru, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90417-0 · Cited by 368 · see citing works

Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses

Shrestha, S., Yang, K., Guy, C. S., Vogel, P., Neale, G. A. M., & Chi, H. (2015) · Nature Immunology · doi:10.1038/ni.3076 · Cited by 366 · see citing works

Oxidative stress in the pathology and treatment of systemic lupus erythematosus

Perl, A. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.147 · Cited by 358 · see citing works

Inhibition of the mTORC Pathway in the Antiphospholipid Syndrome

Canaud, G., Bienaimé, F., Tabarin, F., Bataillon, G., Seilhean, D., Noël, L.-H., Dragon-Durey, M.-A., Snanoudj, R., Friedlander, G., Halbwachs-Mecarelli, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312890 · Cited by 355 · see citing works

Tuberous Sclerosis: from Tubers to mTOR

Kwiatkowski, D. J. (2003) · Annals of Human Genetics · doi:10.1046/j.1469-1809.2003.00012.x · Cited by 340 · see citing works

Rapamycin reduces disease activity and normalizes T cell activation–induced calcium fluxing in patients with systemic lupus erythematosus

Fernández, D., Bonilla, E., Mirza, N., Niland, B. P., & Perl, A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22085 · Cited by 321 · see citing works

Remote Control of Gene Function by Local Translation

Jung, H., Gkogkas, C. G., Sonenberg, N., & Holt, C. E. (2014) · Cell · doi:10.1016/j.cell.2014.03.005 · Cited by 302 · see citing works

Differential Dependence of Hypoxia-inducible Factors 1α and 2α on mTORC1 and mTORC2

Toschi, A., Lee, E., Gadir, N., Ohh, M., & Foster, D. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800170200 · Cited by 301 · see citing works

All cyclophilins and FK506 binding proteins are, individually and collectively, dispensable for viability in Saccharomyces cerevisiae

Dolinski, K. J., Muir, S., Cardenas, M. E., & Heitman, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13093 · Cited by 282 · see citing works

Ribosomal protein S6 kinase activity controls the ribosome biogenesis transcriptional program

Chauvin, C., Koka, V., Nouschi, A., Mieulet, V., Hoareau‐Aveilla, C., Dreazen, A., Cagnard, N., Carpentier, W., Kiss, T., Meyuhas, O., et al. (2013) · Oncogene · doi:10.1038/onc.2012.606 · Cited by 279 · see citing works

Mortality and causes of death in systemic lupus erythematosus

Trager, J., & Ward, M. M. (2001) · Current Opinion in Rheumatology · doi:10.1097/00002281-200109000-00002 · Cited by 264 · see citing works

Current treatment strategies for inhibiting mTOR in cancer.

Chiarini, F., Evangelisti, C., McCubrey, J., & Martelli, A. (2015) · TIPS - Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.11.004 · Cited by 262 · see citing works

Activation of Mammalian Target of Rapamycin Controls the Loss of TCRζ in Lupus T Cells through HRES-1/Rab4-Regulated Lysosomal Degradation

Fernández, D., Caza, T. N., Bonilla, E., Li, Q., Banerjee, S. K., Middleton, F. A., Phillips, P. E., Crow, M. K., Oess, S., Müller‐Esterl, W., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803600 · Cited by 259 · see citing works

Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis

Liu, P., Gan, W., Inuzuka, H., Lazorchak, A. S., Gao, D., Arojo, O., Liu, D., Wan, L., Zhai, B., Yu, Y., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2860 · Cited by 256 · see citing works

FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction

Desai, B. N., Myers, B. R., & Schreiber, S. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261702698 · Cited by 248 · see citing works

Redox regulation of the nutrient-sensitive raptor-mTOR pathway and complex

Sarbassov, D. D., & Sabatini, D. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506096200 · Cited by 248 · see citing works

Mitochondrial reactive oxygen species trigger hypoxia-inducible factor-dependent extension of the replicative life span during hypoxia

Bell, E. L., Klimova, T. A., Eisenbart, J., Schumacker, P. T., & Chandel, N. S. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02265-06 · Cited by 237 · see citing works

The Mammalian Target of Rapamycin Pathway Regulates Nutrient-Sensitive Glucose Uptake in Man

Krebs, M., Brunmair, B., Brehm, A., Artwohl, M., Szendroedi, J., Nowotny, P., Roth, E., Fürnsinn, C., Promintzer, M., Anderwald, C., et al. (2007) · Diabetes · doi:10.2337/db06-1016 · Cited by 230 · see citing works

Evaluating Oxidative Stress in Human Cardiovascular Disease: Methodological Aspects and Considerations

Lee, R., Margaritis, M., Channon, K. M., & Antoniades, C. A. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800493057 · Cited by 228 · see citing works

Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells.

Yeh, W., Bierer, B. E., & McKnight, S. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11086 · Cited by 226 · see citing works

Metabolic control of the Treg/Th17 axis

Barbi, J. J., Pardoll, D. M., & Pan, F. (2013) · Immunological Reviews · doi:10.1111/imr.12029 · Cited by 215 · see citing works

Regulatory T cell proliferative potential is impaired in human autoimmune disease

Carbone, F., Rosa, V. D., Carrieri, P. B., Montella, S., Bruzzese, D., Porcellini, A., Procaccini, C., Cava, A. L., & Matarese, G. (2013) · Nature Medicine · doi:10.1038/nm.3411 · Cited by 214 · see citing works

SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1 α –Dependent Glycolysis

Liu, G., Bi, Y., Shen, B., Yang, H., Zhang, Y., Wang, X., Liu, H., Lu, Y., Liao, J., Chen, X., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2584 · Cited by 203 · see citing works

Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase

Perl, A., Hanczko, R., Caza, T. N., Oaks, Z., & LANDAS, S. K. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.01.014 · Cited by 202 · see citing works

Abnormalities of T cell signaling in systemic lupus erythematosus

Moulton, V. R., & Tsokos, G. C. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3251 · Cited by 198 · see citing works

Duration of Rapamycin Treatment Has Differential Effects on Metabolism in Mice

Fang, Y., Westbrook, R., Hill, C., Boparai, R. K., Arum, O., Spong, A., Wang, F., Javors, M. A., Chen, J., Sun, L. Y., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.02.008 · Cited by 195 · see citing works

Therapeutic targets: MTOR and related pathways

Dancey, J. E. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.9.3175 · Cited by 195 · see citing works

HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE

Caza, T. N., Fernandez, D. R., Talaber, G., Oaks, Z., Haas, M., Madaio, M. P., Lai, Z.-W., Miklossy, G., Singh, R. R., Chudakov, D. M., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203794 · Cited by 193 · see citing works

PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs

Weigelt, B., Warne, P. H., & Downward, J. (2011) · Oncogene · doi:10.1038/onc.2011.42 · Cited by 190 · see citing works

Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin

Perl, A., Hanczko, R., Lai, Z.-W., Oaks, Z., Kelly, R., Borsuk, R., Asara, J. M., & Phillips, P. E. (2015) · Metabolomics · doi:10.1007/s11306-015-0772-0 · Cited by 189 · see citing works

Rapamycin Prolongs Survival and Arrests Pathophysiologic Changes in Murine Systemic Lupus Erythematosus

Warner, L. M., Adams, L. M., & Sehgal, S. N. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370219 · Cited by 180 · see citing works

Mechanistic Target of Rapamycin Complex 1 Expands Th17 and IL-4+ CD4−CD8− Double-Negative T Cells and Contracts Regulatory T Cells in Systemic Lupus Erythematosus

Kato, H., & Perl, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301859 · Cited by 168 · see citing works

mTOR signaling in tumorigenesis

Xu, K. L., Liu, P., & Wei, W. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.10.007 · Cited by 167 · see citing works

Activity of the Novel Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 against T-Cell Acute Lymphoblastic Leukemia

Chiarini, F., Grimaldi, C., Ricci, F., Tazzari, P. L., Evangelisti, C., Ognibene, A., Battistelli, M., Falcieri, E., Melchionda, F., Pession, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1814 · Cited by 166 · see citing works

Dyslipoproteinemia in pediatric systemic lupus erythematosus

Ilowite, N. T., Samuel, P., Ginzler, E. M., & Jacobson, M. S. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310706 · Cited by 165 · see citing works

Prospects for prevention and treatment of cancer with selective PPARγ modulators (SPARMs)

Sporn, M. B., Suh, N., & Mangelsdorf, D. J. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02100-1 · Cited by 159 · see citing works

Structure-Activity Analysis of Niclosamide Reveals Potential Role for Cytoplasmic pH in Control of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling

Fonseca, B. D., Diering, G. H., Bidinosti, M., Dalal, K., Alain, T., Balgi, A. D., Forestieri, R., Nodwell, M., Rajadurai, C. V., Gunaratnam, C., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.359638 · Cited by 159 · see citing works

HYPERLIPIDEMIA IN RENAL TRANSPLANT RECIPIENTS TREATED WITH SIROLIMUS(RAPAMYCIN)

m, C. B., Wilczek, H., Tyd�n, G., ttiger, Y. B., we, J. S., & Groth, C. (1998) · Transplantation · doi:10.1097/00007890-199805150-00023 · Cited by 156 · see citing works

Mechanistic Target of Rapamycin Activation Triggers IL-4 Production and Necrotic Death of Double-Negative T Cells in Patients with Systemic Lupus Erythematosus

Lai, Z., Borsuk, R., Shadakshari, A., Yu, J., Dawood, M., Garcia, R., Francis, L., Tily, H., Bartos, Á., Faraone, S. V., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301005 · Cited by 156 · see citing works

Redox Regulates Mammalian Target of Rapamycin Complex 1 (mTORC1) Activity by Modulating the TSC1/TSC2-Rheb GTPase Pathway

Yoshida, S., Hong, S., Suzuki, T., Nada, S., Mannan, A. M., Wang, J., Okada, M., Guan, K., & Inoki, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.238014 · Cited by 155 · see citing works

FKBP12, the 12-kDa FK506-binding protein, is a physiologic regulator of the cell cycle

Aghdasi, B., Ye, K., Resnick, A. C., Huang, A., Ha, H. C., Guo, X., Dawson, T. M., Dawson, V. L., & Snyder, S. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041614198 · Cited by 147 · see citing works

Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors

Markman, B., Tabernero, J. M., Krop, I. E., Shapiro, G. I., Siu, L. L., Chen, L. C., Mita, M. M., Cuero, M. M., Stutvoet, S., Birle, D. C., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds011 · Cited by 147 · see citing works

Rapamycin Protects Against High Fat Diet–Induced Obesity in C57BL/6J Mice

Chang, G., Chiu, Y., Wu, Y., Chen, W., Liao, J., Chao, T., & Mao, F. C. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08215fp · Cited by 146 · see citing works

ATP-Competitive Inhibitors of mTOR: An Update

Schenone, S., Brullo, C., Musumeci, F., Radi, M., & Botta, M. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796391651 · Cited by 142 · see citing works

Human Double-Negative T Cells in Systemic Lupus Erythematosus Provide Help for IgG and Are Restricted by CD1c

Sieling, P. A., Porcelli, S. A., Duong, B. T., Spada, F. M., Bloom, B. R., Diamond, B., & Hahn, B. H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.5338 · Cited by 132 · see citing works

Improving Type 2 Diabetes Through a Distinct Adrenergic Signaling Pathway Involving mTORC2 That Mediates Glucose Uptake in Skeletal Muscle

Sato, M., Dehvari, N., Öberg, A. I., Dallner, O. S., Sandström, A. L., Olsen, J. M., Csikasz, R. I., Summers, R. J., Hutchinson, D. S., & Bengtsson, T. (2014) · Diabetes · doi:10.2337/db13-1860 · Cited by 128 · see citing works

Sirt2 Deacetylase Is a Novel AKT Binding Partner Critical for AKT Activation by Insulin

Ramakrishnan, G., Davaakhuu, G., Kaplun, L., Chung, W.-C., Rana, A., Atfi, A., Miele, L., & Tzivion, G. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.537266 · Cited by 125 · see citing works

Activation of the p70 S6 Kinase and Phosphorylation of the 4E-BP1 Repressor of mRNA Translation by Type I Interferons

Lekmine, F., Shahab Uddin, M. S., Sassano, A., Parmar, S., Brachmann, S. M., Majchrzak, B., Sonenberg, N., Hay, N., Fish, E. N., & Platanias, L. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301364200 · Cited by 123 · see citing works

Rapamycin inhibits human adipocyte differentiation in primary culture.

Bell, A., Grunder, L., & Sorisky, A. (2000) · Obesity Research · doi:10.1038/oby.2000.29 · Cited by 116 · see citing works

Mechanistic Target of Rapamycin Complex 2 Protects the Heart From Ischemic Damage

Völkers, M., Konstandin, M. H., Doroudgar, S., Toko, H., Quijada, P. J., Din, S., Joyo, A. Y., Ornelas, L., Samse, K., Thuerauf, D. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.003638 · Cited by 115 · see citing works

Long‐term Administration of Rapamycin Reduces Adiposity, but Impairs Glucose Tolerance in High‐Fat Diet‐fed KK/HlJ Mice

Chang, G., Wu, Y., Chiu, Y., Chen, W., Liao, J., Hsu, H., Chao, T., Hung, S., & Mao, F. C. (2009) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00427.x · Cited by 113 · see citing works

Rapamycin reverses status epilepticus-induced memory deficits and dendritic damage

Brewster, A. L., Lugo, J. N., Patil, V. V., Lee, W. L., Qian, Y., Vanegas, F., & Anderson, A. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057808 · Cited by 112 · see citing works

mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus?

Fernández, D., & Perl, A. (2010) · PubMed · Cited by 108 · see citing works

Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine

Hanczko, R., Fernández, D., Doherty, E. H., Qian, Y., Vas, G., Niland, B. P., Caza, T. N., Garba, A. O., Banerjee, S. K., Middleton, F. A., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35722 · Cited by 107 · see citing works

Increased Mitochondrial Electron Transport Chain Activity at Complex I Is Regulated by N -Acetylcysteine in Lymphocytes of Patients with Systemic Lupus Erythematosus

Doherty, E. H., Oaks, Z., & Perl, A. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5702 · Cited by 106 · see citing works

Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulation

Esposito, M., Ruffini, F., Bellone, M., Gagliani, N., Battaglia, M., Martino, G., & Furlan, R. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.01.001 · Cited by 102 · see citing works

STIMULATED RESPONSE OF PERIPHERAL LYMPHOCYTES MAY DISTINGUISH CYCLOSPORINE EFFECT IN RENAL TRANSPLANT RECIPIENTS RECEIVING A CYCLOSPORINE+RAPAMYCIN REGIMEN1

Sindhi, R. K., LaVia, M. F., Paulling, E. E., McMichael, J., Burckart, G. J., Shaw, S., Sindhi, L. A., Livingston, R., Sehgal, S. N., & Jaffe, J. S. (2000) · Transplantation · doi:10.1097/00007890-200002150-00022 · Cited by 101 · see citing works

Systemic lupus erythematosus and “lupus dyslipoproteinemia”

de Carvalho, J. F., Bonfá, E., & Borba, E. F. (2007) · Autoimmunity Reviews · doi:10.1016/j.autrev.2007.11.016 · Cited by 99 · see citing works

S6 kinase inactivation impairs growth and translational target phosphorylation in muscle cells maintaining proper regulation of protein turnover

Mieulet, V., Roceri, M., Espeillac, C., Sotiropoulos, A., Ohanna, M., Oorschot, V., Klumperman, J., Sandri, M., & Pende, M. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00499.2006 · Cited by 99 · see citing works

mTOR complex 2 phosphorylates IMP1 cotranslationally to promote IGF2 production and the proliferation of mouse embryonic fibroblastsPreprint

Dai, N., Christiansen, J., Nielsen, F. C., & Avruch, J. (2013) · Genes & Development · doi:10.1101/gad.209130.112 · Cited by 99 · see citing works

Low levels of total cholesterol, high‐density lipoprotein, and apolipoprotein a1 in association with anticardiolipin antibodies in patients with systemic lupus erythematosus

Lahita, R. G., Rivkin, E., Cavanagh Ms, I., & Romano, P. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361111 · Cited by 90 · see citing works

Enhanced episodic‐like memory and kindling epilepsy in a rat model of tuberous sclerosis

Waltereit, R., Welzl, H., DICHGANS, J., Lipp, H., Schmidt, W., & Weller, M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03538.x · Cited by 80 · see citing works

Functional characterization and mechanism of action of recombinant human kynurenine 3‐hydroxylase

Breton, J., Avanzi, N. R., Magagnin, S., Covini, N., Magistrelli, G., Cozzi, L., & Isacchi, A. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01104.x · Cited by 70 · see citing works

Mechanism-Based Treatment in Tuberous Sclerosis Complex

Jülich, K., & Şahin, M. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2013.12.002 · Cited by 69 · see citing works

Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells

Li, C., Lee, P., Sun, Y., Gu, X., Zhang, E. Y., Guo, Y., Wu, C., Auricchio, N., Priolo, C., Li, J., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131080 · Cited by 67 · see citing works

p53 suppresses carcinoma progression by inhibiting mTOR pathway activation

Akeno, N., Miller, A. L., Ma, X., & Wikenheiser‐Brokamp, K. A. (2014) · Oncogene · doi:10.1038/onc.2013.589 · Cited by 56 · see citing works

An analysis of the metabolic syndrome phenotype in systemic lupus erythematosus

Parker, B., Ahmad, Y. A., Shelmerdine, J., Edlin, H., Yates, A. P., Teh, L., & Bruce, I. N. (2011) · Lupus · doi:10.1177/0961203311416695 · Cited by 54 · see citing works

Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance

Ye, L., Widlund, A. L., Sims, C. A., Lamming, D. W., Guan, Y., Davis, J. G., Sabatini, D. M., Harrison, D. E., Vang, O., & Baur, J. A. (2013) · Aging · doi:10.18632/aging.100576 · Cited by 54 · see citing works

Lipid and lipoprotein levels in premenopausal systemic lupus erythematosus patients

Formiga, F., Meco, J. F., Pintó, X., Jacob, J., Moga, I., & Pujol, R. (2001) · Lupus · doi:10.1191/096120301669070811 · Cited by 52 · see citing works

Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort

Ardoin, S. P., Schanberg, L. E., Sandborg, C. I., Yow, E. S., Barnhart, H., Mieszkalski, K. L., Ilowite, N. T., von Scheven, E., Eberhard, A., Levy, D. M., et al. (2010) · Lupus · doi:10.1177/0961203310373937 · Cited by 46 · see citing works

Metabolic syndrome in patients with systemic lupus erythematosus: association with traditional risk factors for coronary heart disease and lupus characteristics

Telles, R. W., Lanna, C., Ferreira, G. A., & Ribeiro, A. L. P. (2010) · Lupus · doi:10.1177/0961203309359781 · Cited by 46 · see citing works

Matched and mismatched metabolic fuels in lymphocyte function

Caro‐Maldonado, A., Gerriets, V. A., & Rathmell, J. C. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.12.002 · Cited by 44 · see citing works

Rapamycin: In Vitro Profile of a New Immunosuppressive Macrolide.

Sehgal, S. N., & Bansbach, C. C. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb35852.x · Cited by 44 · see citing works

Rapamycin in experimental renal allografts in dogs and pigs.

Collier, D. S., Calne, R. Y., Thiru, S. S., Lim, S. H., Pollard, S. G., Barron, P., Costa, M. D., & White, D. J. (1990) · PubMed · Cited by 44 · see citing works

Rapid non-genomic signalling by 17β-oestradiol through c-Src involves mTOR-dependent expression of HIF-1α in breast cancer cells

Selvaraju, S., Sathya, S., & Lakshmi, B. S. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.349 · Cited by 42 · see citing works

Autoimmune‐mediated reduction of high‐density lipoprotein–cholesterol and paraoxonase 1 activity in systemic lupus erythematosus–prone gld mice

Srivastava, R., Yu, S., Parks, B. W., Black, L. L., & Kabarowski, J. H. S. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27764 · Cited by 41 · see citing works

Potent Dual Inhibitors of TORC1 and TORC2 Complexes (KU-0063794 and KU-0068650) Demonstrate In Vitro and Ex Vivo Anti-Keloid Scar Activity

Syed, F., Sanganee, H. J., Bahl, A. K., & Bayat, A. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.483 · Cited by 39 · see citing works

Requirement of Mammalian Target of Rapamycin Complex 1 Downstream Effectors in Cued Fear Memory Reconsolidation and Its Persistence

Huynh, T. N., Santini, E., & Klann, E. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0878-14.2014 · Cited by 38 · see citing works

Incidence and Risk of Treatment-Related Mortality with mTOR Inhibitors Everolimus and Temsirolimus in Cancer Patients: A Meta-Analysis

Qi, W., Huang, Y., Yao, Y., Shen, Z., & Min, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065166 · Cited by 37 · see citing works

Longevity pathways and memory aging

Gkikas, I., Petratou, D., & Tavernarakis, N. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00155 · Cited by 35 · see citing works

Tuberous Sclerosis and Fulminant Lupus in a Young Woman

Singh, N., Birkenbach, M. P., Caza, T. N., Perl, A., & Cohen, P. L. (2013) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e318289c033 · Cited by 35 · see citing works

Cholesterol levels linked to abnormal plasma thiol concentrations and thiol/disulfide redox status in hyperlipidemic subjects

Kinscherf, R., Cafaltzis, K., Roeder, F., Hildebrandt, W., Edler, L., Deigner, H.-P., Breitkreutz, R., Feussner, G., Kreuzer, J., Werle, E., et al. (2003) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.07.001 · Cited by 34 · see citing works

Glycerol-3-phosphate acyltransferase-4-deficient mice are protected from diet-induced insulin resistance by the enhanced association of mTOR and rictor

Zhang, C., Cooper, D. E., Grevengoed, T. J., Li, L. O., Klett, E. L., Eaton, J. M., Harris, T. E., & Coleman, R. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00034.2014 · Cited by 33 · see citing works

Dose-Related Increase of HDL-cholesterol Levels after N-acetylcysteine in Man

Franceschini, G., Werba, J. P., Safa, O., Gikalov, I., & Sirtori, C. R. (1993) · Pharmacological Research · doi:10.1006/phrs.1993.1124 · Cited by 19 · see citing works

Rapamycin‐sensitive signals control TCR/CD28‐driven Ifng, Il4 and Foxp3 transcription and promoter region methylation

Tomasoni, R., Basso, V., Pilipow, K., Sitia, G., Saccani, S., Agresti, A., Mietton, F., Natoli, G., Colombetti, S., & Mondino, A. (2011) · European Journal of Immunology · doi:10.1002/eji.201041130 · Cited by 19 · see citing works

mTOR complex 2 mediates Akt phosphorylation that requires PKCε in adult cardiac muscle cells

Moschella, P., McKillop, J. C., Pleasant, D. L., Harston, R. K., Balasubramanian, S., & Kuppuswamy, D. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.05.001 · Cited by 18 · see citing works

PTENtiating autoimmunity through Treg cell deregulation

Ray, J. P., & Craft, J. E. (2015) · Nature Immunology · doi:10.1038/ni.3082 · Cited by 14 · see citing works

Treatment-related fatigue with everolimus and temsirolimus in patients with cancer—a meta-analysis of clinical trials

Peng, L., Zhou, Y., Ye, X., & Zhao, Q. (2014) · Tumor Biology · doi:10.1007/s13277-014-2669-3 · Cited by 14 · see citing works

Mitochondrial dysfunction and oxidative stress in aging and cancer

Kudryavtseva, A. V., Krasnov, G. S., Dmitriev, A. A., Alekseev, B. Y., Kardymon, O. L., Садритдинова, А. Ф., Fedorova, M., Pokrovsky, A. V., Melnikova, N. V., Каприн, А. Д., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9821 · Cited by 551 · see citing works

Moving towards personalized treatments of immune-related adverse events

Esfahani, K., Elkrief, A., Calabrese, C., Lapointe, R., Hudson, M., Routy, B., Miller, W. H., & Calabrese, L. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0352-8 · Cited by 351 · see citing works

Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases

Perl, A. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.172 · Cited by 335 · see citing works

Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches

Hussain, R., Zubair, H., Sarah, P., & Shahab, M. (2018) · Brain Sciences · doi:10.3390/brainsci8090177 · Cited by 233 · see citing works

Immune senescence, epigenetics and autoimmunity

Ray, D., & Yung, R. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.04.002 · Cited by 219 · see citing works

mTOR Regulation of Glycolytic Metabolism in T Cells

Salmond, R. J. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00122 · Cited by 211 · see citing works

Acne vulgaris: The metabolic syndrome of the pilosebaceous follicle

Melnik, B. C. (2017) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2017.09.006 · Cited by 197 · see citing works

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors)

Reinwald, M., Silva, J. T., Mueller, N. J., Fortün, J., Garzoni, C., de Fijter, J. W., Fernández‐Ruiz, M., Grossi, P., & Aguado, J. M. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.02.009 · Cited by 178 · see citing works

Functional and Phenotypic Plasticity of CD4+T Cell Subsets

Caza, T. N., & LANDAS, S. K. (2015) · BioMed Research International · doi:10.1155/2015/521957 · Cited by 156 · see citing works

Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6 blockade–refractory idiopathic multicentric Castleman disease

Fajgenbaum, D. C., Langan, R.-A., Japp, A. S., Partridge, H. L., Pierson, S. K., Singh, A., Arenas, D. J., Ruth, J. R., Nabel, C. S., Stone, K., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126091 · Cited by 147 · see citing works

Cancer and mTOR Inhibitors in Transplant Recipients

de Fijter, J. W. (2016) · Transplantation · doi:10.1097/tp.0000000000001447 · Cited by 147 · see citing works

Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine

Ibrahim, H., Perl, A., Smith, D. E., Lewis, T. C., Kon, Z. N., Goldenberg, R., Yarta, K., Staniloae, C. S., & Williams, M. R. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108544 · Cited by 146 · see citing works

Fasting enhances cold resistance in fish through stimulating lipid catabolism and autophagy

Lu, D., Ma, Q., Wang, J., Li, L., Han, S., Limbu, S. M., Li, D., Chen, L., Zhang, M., & Du, Z. (2019) · The Journal of Physiology · doi:10.1113/jp277091 · Cited by 143 · see citing works

mTOR: A Cellular Regulator Interface in Health and Disease

Boutouja, F., Stiehm, C. M., & Platta, H. W. (2019) · Cells · doi:10.3390/cells8010018 · Cited by 136 · see citing works

PI3K/AKT/mTOR Pathway in Ovarian Cancer Treatment: Are We on the Right Track?

Gasparri, M. L., Bardhi, E., Ruscito, I., Papadia, A., Farooqı, A. A., Marchetti, C., Bogani, G., Ceccacci, I., Mueller, M. D., & Panici, P. B. (2017) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0043-118907 · Cited by 136 · see citing works

Roles of mTOR Signaling in Tissue Regeneration

Wei, X., Luo, L., & Chen, J.-Z. (2019) · Cells · doi:10.3390/cells8091075 · Cited by 132 · see citing works

T follicular helper cells in autoimmune diseases

Wei, X., & Niu, X. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102976 · Cited by 130 · see citing works

Chronic inflammation and sarcopenia: A regenerative cell therapy perspective

Chhetri, J. K., Barreto, P. D. S., Fougère, B., Rolland, Y., Vellas, B. J., & Cesari, M. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2017.12.023 · Cited by 127 · see citing works

Autophagy and Rheumatoid Arthritis: Current Knowledges and Future Perspectives

Vomero, M., Barbati, C., Colasanti, T., Perricone, C., Novelli, L., Ceccarelli, F., Spinelli, F. R., Franco, M. D., Conti, F., Valesini, G., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01577 · Cited by 116 · see citing works

Milk’s Role as an Epigenetic Regulator in Health and Disease

Melnik, B. C., & Schmitz, G. (2017) · Diseases · doi:10.3390/diseases5010012 · Cited by 113 · see citing works

Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation

Esfahani, K., Al-Aubodah, T.-A., Thebault, P., Lapointe, R., Hudson, M., Johnson, N. A., Baran, D., Bhulaiga, N., Takano, T., Cailhier, J.-F., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12628-1 · Cited by 109 · see citing works

T helper 17 cell/regulatory T-cell imbalance in hidradenitis suppurativa/acne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities

Melnik, B. C., John, S. M., Chen, W., & Plewig, G. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16561 · Cited by 108 · see citing works

Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors

Lee, D. J., Lee, H. J., Farmer, J. R., & Reynolds, K. L. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01530-2 · Cited by 102 · see citing works

Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity

Katsuyama, T., Li, H., Comte, D., Tsokos, G. C., & Moulton, V. R. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127949 · Cited by 97 · see citing works

Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years

Oaks, Z., Winans, T., Huang, N., Bánki, K., & Perl, A. (2016) · Current Rheumatology Reports · doi:10.1007/s11926-016-0622-8 · Cited by 93 · see citing works

Cytoplasmic DNA sensing by KU complex in aged CD4(+) T cell potentiates T cell activation and aging-related autoimmune inflammation

Wang, Y., Fu, Z., Li, X., Liang, Y., Pei, S., Hao, S., Zhu, Q., Yu, T., Pei, Y., Yuan, J., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.02.003 · Cited by 84 · see citing works

Oxidative Stress and Treg and Th17 Dysfunction in Systemic Lupus Erythematosus

Yang, J. Y., Yang, X., Zou, H., & Li, M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2526174 · Cited by 85 · see citing works

Amino Acids Regulate mTORC1 by an Obligate Two-step Mechanism*

Dyachok, J., Earnest, S. A., Iturraran, E. N., Cobb, M., & Ross, E. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.732511 · Cited by 75 · see citing works

Inhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA/2J glaucoma

Williams, P. A., Braine, C., Kizhatil, K., Foxworth, N. E., Tolman, N. G., Harder, J. M., Scott, R. A., Sousa, G. L., Panitch, A., Howell, G. R., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0303-3 · Cited by 79 · see citing works

Curcumin supplementation in pediatric patients: A systematic review of current clinical evidence

Heidari, Z., Daei, M., Boozari, M., Jamialahmadi, T., & Sahebkar, A. (2021) · Phytotherapy Research · doi:10.1002/ptr.7350 · Cited by 80 · see citing works

Oxidative Stress, Maternal Diabetes, and Autism Spectrum Disorders

Carpita, B., Muti, D., & Dell’Osso, L. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3717215 · Cited by 79 · see citing works

TPC2 polymorphisms associated with a hair pigmentation phenotype in humans result in gain of channel function by independent mechanisms

Chao, Y., Schludi, V., Chen, C., Butz, E. S., Nguyen, O. N. P., Müller, M. J., Krüger, J., Kammerbauer, C., Johny, M. B., Vollmar, A. M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705739114 · Cited by 74 · see citing works

Biotin Deficiency Induces Th1- and Th17-Mediated Proinflammatory Responses in Human CD4+ T Lymphocytes via Activation of the mTOR Signaling Pathway

Elahi, A., Sabui, S., Narasappa, N., Agrawal, S., Lambrecht, N. W. G., Agrawal, A., & Said, H. M. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701200 · Cited by 70 · see citing works

Systemic lupus erythematosus: pathogenesis and targeted therapy

Su, X., Yu, H. M., Lei, Q., Chen, X., Tong, Y., Zhang, Z., Yang, W., Guo, Y., & Lin, L. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00217-8 · Cited by 84 · see citing works

Role of autophagy in the pathogenesis of rheumatoid arthritis: Latest evidence and therapeutic approaches

Karami, J., Masoumi, M., Khorramdelazad, H., Bashiri, H., Darvishi, P., Sereshki, H. A., Shekarabi, M., & Sahebkar, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117734 · Cited by 70 · see citing works

From mucolipidosis type IV to Ebola: TRPML and two-pore channels at the crossroads of endo-lysosomal trafficking and disease

Grimm, C. M., Butz, E. S., Chen, C., Wahl‐Schott, C., & Biel, M. (2017) · Cell Calcium · doi:10.1016/j.ceca.2017.04.003 · Cited by 68 · see citing works

Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer

Karimi, K., Lindgren, T., Koch, C. A., & Brodell, R. T. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9393-9 · Cited by 67 · see citing works

Genistein protects against ox-LDL-induced senescence through enhancing SIRT1/LKB1/AMPK-mediated autophagy flux in HUVECs

Zhang, H., Yang, X., Pang, X.-F., Zhao, Z., Yu, H., & Zhou, H. M. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3476-8 · Cited by 64 · see citing works

Advances in systemic lupus erythematosus pathogenesis via mTOR signaling pathway

He, J., Ma, J., Ren, B., & Liu, A. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.09.022 · Cited by 64 · see citing works

Metformin Inhibits the Type 1 IFN Response in Human CD4+ T Cells

Titov, A. A., Baker, H. V., Brusko, T. M., Sobel, E. S., & Morel, L. M. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801651 · Cited by 61 · see citing works

Molecular pathology endpoints useful for aging studies

Niedernhofer, L. J., Kirkland, J. L., & Ladiges, W. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.012 · Cited by 59 · see citing works

BCAP links IL-1R to the PI3K–mTOR pathway and regulates pathogenic Th17 cell differentiation

Deason, K. L., Troutman, T. D., Jain, A., Challa, D. K., Mandraju, R., Brewer, T., Ward, E. S., & Pasare, C. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20171810 · Cited by 60 · see citing works

Pathogenesis and treatment of autoimmune rheumatic diseases

Liu, E. V., & Perl, A. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000594 · Cited by 59 · see citing works

Mitochondrial-encoded MOTS-c prevents pancreatic islet destruction in autoimmune diabetes

Kong, B. S., Min, S. H., Lee, C. D., & Cho, Y. M. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109447 · Cited by 62 · see citing works

Age-Associated DNA Methylation Changes in Naive CD4 + T Cells Suggest an Evolving Autoimmune Epigenotype in Aging T Cells

Dozmorov, M. G., Coit, P., Maksimowicz‐McKinnon, K., & Sawalha, A. H. (2017) · Epigenomics · doi:10.2217/epi-2016-0143 · Cited by 58 · see citing works

Molecular and Cellular Bases of Immunosenescence, Inflammation, and Cardiovascular Complications Mimicking “Inflammaging” in Patients with Systemic Lupus Erythematosus

Tsai, C., Shen, C., Liao, H., Li, K., Lee, H.-T., Lu, C.-S., Wu, C.-H., Kuo, Y., Hsieh, S., & Yu, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163878 · Cited by 57 · see citing works

Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation

Zhuang, Q., Cai, H., Cao, Q., Li, Z., Liu, S., & Ming, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.552988 · Cited by 55 · see citing works

Renal mTORC1 activation is associated with disease activity and prognosis in lupus nephritis

Mao, Z., Tan, Y. C. R. S., Tao, J., Li, L., Wang, H., Yu, F., Perl, A., & Zhao, M. (2022) · Rheumatology · doi:10.1093/rheumatology/keac037 · Cited by 55 · see citing works

Involvement of PINK1/Parkin-mediated mitophagy in AGE-induced cardiomyocyte aging

Zha, Z., Wang, J., Wang, X., Lu, M., & Guo, Y. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.161 · Cited by 55 · see citing works

Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis

Tan, V. X., & Guillemin, G. J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01013 · Cited by 52 · see citing works

The Role of Autophagy in Lupus Nephritis

Wang, L., & Law, H. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025154 · Cited by 54 · see citing works

Metformin alleviated endotoxemia-induced acute lung injury via restoring AMPK-dependent suppression of mTOR

Wu, K., Tian, R., Huang, J., Yang, Y., Dai, J., Jiang, R., & Zhang, L. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.05.018 · Cited by 54 · see citing works

Endothelial cell and T‐cell crosstalk: Targeting metabolism as a therapeutic approach in chronic inflammation

Certo, M., Elkafrawy, H., Pucino, V., Cucchi, D., Cheung, K. C.-P., & Mauro, C. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15002 · Cited by 52 · see citing works

Immunosenescence of T cells: a key player in rheumatoid arthritis

Gao, Y. Q., Cai, W., Zhou, Y., Li, Y., Cheng, J., & Wei, F. (2022) · Inflammation Research · doi:10.1007/s00011-022-01649-0 · Cited by 53 · see citing works

Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)

Li, Q., Marcoux, G., Hu, Y., Rebetz, J., Guo, L., Semple, E., Provan, D., Xu, S., Hou, M., Peng, J., et al. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103677 · Cited by 56 · see citing works

Metabolic Targets for Treatment of Autoimmune Diseases

Piranavan, P., Bhamra, M. S., & Perl, A. (2020) · Immunometabolism · doi:10.20900/immunometab20200012 · Cited by 52 · see citing works

Hyperphosphatemia Promotes Senescence of Myoblasts by Impairing Autophagy Through Ilk Overexpression, A Possible Mechanism Involved in Sarcopenia

Sosa, P., Alcalde‐Estévez, E., Plaza, P., Troyano, N., Alonso, C., Martínez‐Arias, L., Aroeira, A. E. D. M., Rodrı́guez-Puyol, D., Olmos, G., López‐Ongil, S., et al. (2018) · Aging and Disease · doi:10.14336/ad.2017.1214 · Cited by 49 · see citing works

Impact of nutrient overload on metabolic homeostasis

Qiu, H., & Schlegel, V. L. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nuy023 · Cited by 48 · see citing works

Metabolic reprogramming in memory CD4 T cell responses of old adults

Yanes, R. E., Zhang, H., Shen, Y., Weyand, C. M., & Goronzy, J. J. (2019) · Clinical Immunology · doi:10.1016/j.clim.2019.07.003 · Cited by 47 · see citing works

Non-alcoholic Fatty Liver Disease Induced by Perinatal Exposure to Bisphenol a Is Associated With Activated mTOR and TLR4/NF-κB Signaling Pathways in Offspring Rats

Lin, R., Wu, D., Wu, F., Meng, Y., Zhang, J.-H., Wang, X.-G., & Jia, L. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00620 · Cited by 46 · see citing works

Immunoengineering through cancer vaccines – A personalized and multi-step vaccine approach towards precise cancer immunity

Lybaert, L., Vermaelen, K. Y., Geest, B. G. D., & Nuhn, L. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.09.009 · Cited by 46 · see citing works

Human SLC15A4 is crucial for TLR-mediated type I interferon production and mitochondrial integrity

Kobayashi, T., Nguyen-Tien, D., Ohshima, D., Karyu, H., Shimabukuro-Demoto, S., Yoshida-Sugitani, R., & Toyama‐Sorimachi, N. (2021) · International Immunology · doi:10.1093/intimm/dxab006 · Cited by 45 · see citing works

mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency

Winans, T., Oaks, Z., Choudhary, G., Patel, A., Huang, N., Faludi, T., Krakkó, D., Nolan, J. P., Lewis, J., Blair, S., et al. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103112 · Cited by 44 · see citing works

Tumor-like microenvironment in oral lichen planus: evidence of malignant transformation?

Peng, Q., Zhang, J., Ye, X., & Zhou, G. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1295852 · Cited by 43 · see citing works

Sirolimus as Rescue Therapy for Refractory/Relapsed Immune Thrombocytopenia: Results of a Single-Center, Prospective, Single-Arm Study

Feng, Y., Xiao, Y., Yan, H., Wang, P., Zhu, W., Cassady, K. M., Zou, Z., Wang, K., Chen, T., Yao, Q., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00110 · Cited by 44 · see citing works

GLUT-1 Enhances Glycolysis, Oxidative Stress, and Fibroblast Proliferation in Keloid

Lu, Y., Wu, C., Hong, C., Chang, K., & Lee, C. (2021) · Life · doi:10.3390/life11060505 · Cited by 43 · see citing works

Nanomedicines Targeting Metabolic Pathways in the Tumor Microenvironment: Future Perspectives and the Role of AI

Fan, S., Wang, W., Che, W., Xu, Y., Jin, C., Dong, L., & Xia, Q. (2025) · Metabolites · doi:10.3390/metabo15030201 · Cited by 43 · see citing works

Novel Role of the Mitochondrial Protein Fus1 in Protection from Premature Hearing Loss via Regulation of Oxidative Stress and Nutrient and Energy Sensing Pathways in the Inner Ear

Tan, W. J. T., Song, L., Graham, M. M., Schettino, A. E., Navaratnam, D. S., Yarbrough, W. G., Santos‐Sacchi, J., & Ivanova, A. V. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6851 · Cited by 42 · see citing works

Protective Role of mTOR in Liver Ischemia/Reperfusion Injury: Involvement of Inflammation and Autophagy

Zhang, T., Guo, J., Gu, J., Chen, K., Li, H.-L., & Wang, J.-L. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7861290 · Cited by 40 · see citing works

Splicing factor SRSF1 controls T cell homeostasis and its decreased levels are linked to lymphopenia in systemic lupus erythematosus

Katsuyama, T., Juárez, I., Krishfield, S., Kyttaris, V. C., & Moulton, V. R. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa094 · Cited by 40 · see citing works

Lifetime Impact of Cow’s Milk on Overactivation of mTORC1: From Fetal to Childhood Overgrowth, Acne, Diabetes, Cancers, and Neurodegeneration

Melnik, B. C. (2021) · Biomolecules · doi:10.3390/biom11030404 · Cited by 42 · see citing works

Unraveling the Role of Ataxin-2 in Metabolism

Carmo‐Silva, S., Nóbrega, C., de Almeida, L. P., & Cavadas, C. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.12.006 · Cited by 40 · see citing works

Stimulation of ovarian follicle growth after AMPK inhibition

Lu, X., Guo, S., Cheng, Y., Kim, J.-H., Feng, Y., & Feng, Y. (2017) · Reproduction · doi:10.1530/rep-16-0577 · Cited by 40 · see citing works

T-cell senescence: A crucial player in autoimmune diseases

Lu, Y., Ruan, Y., Pan, H., Rui, K., Liu, Q., Wang, S., & Cui, D. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109202 · Cited by 37 · see citing works

Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas

Liu, M., Lin, Y., Zhang, X.-C., Tan, Y., Yao, Y., Tan, J., Zhang, X., Cui, Y., Liu, X., Wang, Y., et al. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.70 · Cited by 37 · see citing works

mTOR in metabolic homeostasis and disease.

Liu, X., Guo, B., Li, Q., & Nie, J. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114173 · Cited by 35 · see citing works

Metabolic pathways mediate pathogenesis and offer targets for treatment in rheumatic diseases

Wyman, B., & Perl, A. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000687 · Cited by 35 · see citing works

FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies

Shen, W., Zhou, Q., Peng, C., Li, J., Yuan, Q., Zhu, H., Zhao, M., Jiang, X., Liu, W., & Ren, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.880077 · Cited by 36 · see citing works

Reverse Expression of Aging-Associated Molecules through Transfection of miRNAs to Aged Mice

Kim, J., Lee, B., Choi, E., Lee, K., Choi, S., Cho, J. H., Jeon, W. B., & Kim, E. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2016.11.005 · Cited by 34 · see citing works

Targeting HMGB1 by ethyl pyruvate ameliorates systemic lupus erythematosus and reverses the senescent phenotype of bone marrow-mesenchymal stem cells

Ji, J., Fu, T., Dong, C., Zhu, W., Yang, J., Kong, X., Zhang, Z., Bao, Y., Zhao, R. Z., Ge, X., et al. (2019) · Aging · doi:10.18632/aging.102052 · Cited by 34 · see citing works

Therapeutic Potential of Exploiting Autophagy Cascade Against Coronavirus Infection

Maity, S., & Saha, A. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.675419 · Cited by 28 · see citing works

Dendritic Cells: Versatile Players in Renal Transplantation

Lin, J., Wang, H., Liu, C., Cheng, A., Deng, Q., Zhu, H., & Chen, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.654540 · Cited by 34 · see citing works

Systemic lupus erythematosus: review of synthetic drugs

Tsang-A-Sjoe, M. W. P., & Bultink, I. E. M. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1101448 · Cited by 33 · see citing works

Targeting Mechanistic Target of Rapamycin Complex 1 Restricts Proinflammatory T Cell Differentiation and Ameliorates Takayasu Arteritis

Zhang, J., Zhao, L., Wang, J., Cheng, Z., Sun, M., Zhao, J., Liu, B., Liu, X., Wen, Z., & Li, Z. (2019) · Arthritis & Rheumatology · doi:10.1002/art.41084 · Cited by 33 · see citing works

Protective effects of glucagon‐like peptide‐1 on cardiac remodeling by inhibiting oxidative stress through mammalian target of rapamycin complex 1/p70 ribosomal protein S6 kinase pathway in diabetes mellitus

Wang, D., Jiang, L., Feng, B., He, N., Zhang, Y., & Ye, H. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13098 · Cited by 31 · see citing works

SMCR8 negatively regulates AKT and MTORC1 signaling to modulate lysosome biogenesis and tissue homeostasis

Lan, Y., Sullivan, P. M., & Hu, F. (2019) · Autophagy · doi:10.1080/15548627.2019.1569914 · Cited by 31 · see citing works

Theobromine ameliorates nonalcoholic fatty liver disease by regulating hepatic lipid metabolism via mTOR signaling pathway in vivo and in vitro

Wei, D., Wu, S., Liu, J., Zhang, X., Guan, X., Gao, L., & Xu, Z. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2020-0259 · Cited by 31 · see citing works

Influence of Disease Duration on Circulating Levels of miRNAs in Children and Adolescents with New Onset Type 1 Diabetes

Samandari, N., Mirza, A. H., Kaur, S., Hougaard, P., Nielsen, L. B., Fredheim, S., Mortensen, H. B., & Pociot, F. (2018) · Non-Coding RNA · doi:10.3390/ncrna4040035 · Cited by 31 · see citing works

mTOR signaling: A pivotal player in Treg cell dysfunction in systemic lupus erythematosus

Zhao, X., Wang, S., Wang, S., Xie, J., & Cui, D. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109153 · Cited by 30 · see citing works

TNFAIP8L2/TIPE2 impairs autolysosome reformation via modulating the RAC1-MTORC1 axis

Li, W., Li, Y., Guan, Y., Du, Y., Zhao, M., Chen, X., Zhu, F., Guo, C. H., Jia, Y., Li, Y., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1761748 · Cited by 29 · see citing works

Pasteurized non-fermented cow’s milk but not fermented milk is a promoter of mTORC1-driven aging and increased mortality

Melnik, B. C., & Schmitz, G. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101270 · Cited by 29 · see citing works

Recent advances in development of hetero-bivalent kinase inhibitors

Lee, S., Kim, J., Jo, J., Chang, J. W., Sim, J., & Yun, H. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113318 · Cited by 29 · see citing works

FSHR-mTOR-HIF1 signaling alleviates mouse follicles from AMPK-induced atresia

Liu, L., Hao, M., Zhang, J., Chen, Z., Zhou, J., Wang, C., Zhang, H., & Wang, J. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113158 · Cited by 29 · see citing works

Increased Expression of EZH2 Is Mediated by Higher Glycolysis and mTORC1 Activation in Lupus CD4+ T Cells

Zheng, X., Tsou, P., & Sawalha, A. H. (2020) · Immunometabolism · doi:10.20900/immunometab20200013 · Cited by 27 · see citing works

Metabolism of murine TH17 cells: Impact on cell fate and function

Wang, R., & Solt, L. A. (2016) · European Journal of Immunology · doi:10.1002/eji.201545788 · Cited by 27 · see citing works

Exploiting immune cell metabolic machinery for functional HIV cure and the prevention of inflammaging

Palmer, C. S., Palchaudhuri, R., Albargy, H. A., Abdel‐Mohsen, M., & Crowe, S. M. (2018) · F1000Research · doi:10.12688/f1000research.11881.1 · Cited by 27 · see citing works

Chronic administration of theobromine inhibits mTOR signal in rats

Sugimoto, N., Katakura, M., Matsuzaki, K., Sumiyoshi, E., Yachie, A., & Shido, O. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13175 · Cited by 26 · see citing works

Immune biomarkers in the spectrum of childhood noncommunicable diseases

Skevaki, C. L., van den Berg, J., Jones, N., Garssen, J., Vuillermin, P., Levin, M. E., LANDAY, A. L., Renz, H. E., Calder, P. C., & Thornton, C. A. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.03.012 · Cited by 27 · see citing works

Glutaminolysis is required in maintaining immune regulatory functions in B cells

Liu, J., Geng, X., Hu, T., Mo, L., Luo, X., Qiu, S., Liu, D., Liu, Z.-G., Shao, J., Liu, Z.-Q., et al. (2022) · Mucosal Immunology · doi:10.1038/s41385-021-00481-9 · Cited by 26 · see citing works

Getting old through the blood: circulating molecules in aging and senescence of cardiovascular regenerative cells

Angelini, F., Pagano, F., Bordin, A., Picchio, V., De Falco, E., & Chimenti, I. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00062 · Cited by 25 · see citing works

Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases

Perl, A. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.172 · Cited by 335 · see citing works

mTOR: A Cellular Regulator Interface in Health and Disease

Boutouja, F., Stiehm, C. M., & Platta, H. W. (2019) · Cells · doi:10.3390/cells8010018 · Cited by 136 · see citing works

mTOR Signaling and Metabolic Regulation of T Cells: New Potential Therapeutic Targets in Autoimmune Diseases

Pierdominici, M., Vacirca, D., Delunardo, F., & Ortona, E. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798357809 · Cited by 29 · see citing works

Roles of Mechanistic Target of Rapamycin in the Adaptive and Innate Immune Systems

Kato, H., & Perl, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802733-2.00024-4 · Cited by 3 · see citing works

Therapeutic mTOR blockade in systemic autoimmunity: Implications for antiviral immunity and extension of lifespan

Geier, C., & Perl, A. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102984 · Cited by 39 · see citing works